UCM1400

UCM1400 is a melatonin receptor (MT) subtype-selective modulator. It acts as an agonist on MT1 with a pKi value of 7.94 and as an antagonist on MT2 with a pKi value of 8.11. UCM1400 inhibits MT2 receptor-mediated reduction of cyclic adenosine monophosphate (cAMP) with a pIC50 value of 7.87. It exhibits antiproliferative activity on human glioma cells and inhibits tumor growth, making it a potential candidate for cancer research, including studies on gliomas.